Literature DB >> 33519812

MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication Via Targeting Tripartite Motif Protein 25.

Jia Li1, Yewei Xie1, Liwei Li2,3, Xiaobing Li1, Li Shen1, Jin Gong1, Rufang Zhang1.   

Abstract

Viral myocarditis is caused by a viral infection and characterized by the inflammation of the myocardium. Coxsackievirus B3 (CVB3) infection is one of the most common among the infections caused by this virus. The host's early innate immune response to CVB3 infection particularly depends on the functions of type I interferons (IFNs). In this study, we report that a host microRNA, miR-30a, was upregulated by CVB3 to facilitate its replication. We demonstrated that miR-30a was a potent negative regulator of IFN-I signaling by targeting tripartite motif protein 25 (TRIM25). In addition, we found that TRIM25 overexpression significantly suppressed CVB3 replication, whereas TRIM25 knockdown increased viral titer and VP1 protein expression. MiR-30a inhibits the expression of TRIM25 and TRIM25-mediated retinoic acid-inducible gene (RIG)-I ubiquitination to suppress IFN-β activation and production, thereby resulting in the enhancement of CVB3 replication. These results indicate the proviral role of miR-30a in modulating CVB3 infection for the first time. This not only provides a new strategy followed by CVB3 in order to modulate IFN-I-mediated antiviral immune responses by engaging host miR-30a but also improves our understanding of its pathogenesis.
Copyright © 2021 Li, Xie, Li, Li, Shen, Gong and Zhang.

Entities:  

Keywords:  CVB3; TRIM25; miR-30a; type I IFN responses; viral replication

Mesh:

Substances:

Year:  2021        PMID: 33519812      PMCID: PMC7840606          DOI: 10.3389/fimmu.2020.603437

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  37 in total

1.  Suppression of microRNA-silencing pathway by HIV-1 during virus replication.

Authors:  Robinson Triboulet; Bernard Mari; Yea-Lih Lin; Christine Chable-Bessia; Yamina Bennasser; Kevin Lebrigand; Bruno Cardinaud; Thomas Maurin; Pascal Barbry; Vincent Baillat; Jacques Reynes; Pierre Corbeau; Kuan-Teh Jeang; Monsef Benkirane
Journal:  Science       Date:  2007-02-22       Impact factor: 47.728

Review 2.  Viral and cellular microRNAs as determinants of viral pathogenesis and immunity.

Authors:  Eva Gottwein; Bryan R Cullen
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

3.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-07-03       Impact factor: 29.983

4.  Inducible MicroRNA-3570 Feedback Inhibits the RIG-I-Dependent Innate Immune Response to Rhabdovirus in Teleost Fish by Targeting MAVS/IPS-1.

Authors:  Tianjun Xu; Qing Chu; Junxia Cui; Dekun Bi
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

5.  MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization.

Authors:  Weihui Gou; Zhen Zhang; Chunfeng Yang; Yumei Li
Journal:  Exp Cell Res       Date:  2018-03-07       Impact factor: 3.905

Review 6.  Update on coxsackievirus B3 myocarditis.

Authors:  DeLisa Fairweather; Katelyn A Stafford; Yoon K Sung
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

Review 7.  Viral myocarditis--diagnosis, treatment options, and current controversies.

Authors:  Ari Pollack; Amy R Kontorovich; Valentin Fuster; G William Dec
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

Review 8.  The role of Trim25 in development, disease and RNA metabolism.

Authors:  Gregory Heikel; Nila Roy Choudhury; Gracjan Michlewski
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

9.  TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.

Authors:  Hui Liu; Min Li; Yahui Song; Wei Xu
Journal:  Front Immunol       Date:  2018-10-25       Impact factor: 7.561

10.  The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway.

Authors:  Feng He; Zonghui Xiao; Hailan Yao; Sen Li; Miao Feng; Wei Wang; Zhewei Liu; Zhuo Liu; Jianxin Wu
Journal:  J Transl Med       Date:  2019-10-04       Impact factor: 5.531

View more
  2 in total

1.  The circRNA circSIAE Inhibits Replication of Coxsackie Virus B3 by Targeting miR-331-3p and Thousand and One Amino-Acid Kinase 2.

Authors:  Qingru Yang; Yuhan Li; Yan Wang; Xiaorong Qiao; Tingjun Liu; Hua Wang; Hongxing Shen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-24       Impact factor: 5.293

2.  A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

Authors:  Yulemi Gonzalez Quesada; Luc DesGroseillers
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.